Reuters logo
BRIEF-Zafgen preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile
June 6, 2017 / 9:36 PM / in 6 months

BRIEF-Zafgen preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile

June 6 (Reuters) - Zafgen Inc:

* Zafgen to present two late-breaking abstracts for zgn-1061 at the american diabetes association 77th scientific sessions

* Preclinical abstract will present results for zgn-1061 on glycemic control, weight loss and safety profile

* Clinical abstract will provide full data set from zgn-1061 phase 1 clinical trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below